Abstract 16601: APD811, a Novel and Highly Selective Non-prostanoid IP Receptor Agonist in Smooth Muscle Cells From Patients With Pulmonary HypertensionLei Shen, Lucie H. Clapp, John Adams et al.|Circulation|2016Cited by 1
RALINEPAG REDUCES PULMONARY VASCULAR RESISTANCE (PVR) IN A PHASE 2 STUDY CONFIRMING PRECLINICAL FINDINGS ON PROSTACYCLIN (IP) RECEPTORS IN HUMAN TISSUESIoana R. Preston, Lucie H. Clapp, Linda Cadaret et al.|CHEST Journal|2018Cited by 1
5021APD811 (ralinepag), a novel non-prostanoid IP receptor agonist, has potent antiproliferative and vasorelaxant properties in human pulmonary arteryLei Shen, Lucie H. Clapp, Dominic P. Behan et al.|European Heart Journal|2017Cited by 0
The non-prostanoid IP receptor agonist, APD811 (ralinepag) has potent antiproliferative and vasorelaxant properties in human pulmonary arteryJohn Adams, Dominic P. Behan, Lei Shen et al.|Unknown|2017Cited by 0
APD811 (ralinepag), a novel non-prostanoid IP receptor agonist, has potent antiproliferative and vasorelaxant properties in human pulmonary arteryLinghong Shen, Lucie H. Clapp, Jitesh A. Patel et al.|UCL Discovery (University College London)|2017Cited by 0